Biosimilars: controversies as illustrated by rhGH-Reference-Cited by-同舟云学术

Biosimilars: controversies as illustrated by rhGH

Published:2010-03-22 Issue:5 Volume:26 Page:1219-1229
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Declerck Paul J.¹,Darendeliler Feyza²,Góth Miklós³,Kolouskova Stanislava⁴,Micle Ioana⁵⁶,Noordam Cees⁷,Peterkova Valentina⁸,Volevodz Natalia N.⁸,Zapletalová Jiřina⁹,Ranke Michael B.¹⁰

Affiliation:

1. Faculty of Pharmaceutical Sciences, K.U. Leuven, Leuven, Belgium

2. Istanbul Faculty of Medicine, Istanbul, Turkey

3. Second Department of Internal Medicine, State Health Centre, Budapest, Hungary

4. University Hospital Motol, Prague, Czech Republic

5. University of Medicine and Pharmacy Victor Babes, Timisoara, Romania

6. Clinical Emergency Hospital for Children Louis Turcanu, Timisoara, Romania

7. Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands

8. Endocrinological Scientific Centre, Russian Academy of Science, Moscow, Russian Federation

9. University Hospital and Faculty of Medicine, Palacky University, Olomouc, Czech Republic

10. University Children’s Hospital, Tübingen, Germany

Publisher

Informa Healthcare

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1185/03007991003719642

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biopharmaceutical product development strategies;Conceptual Development of Industrial Biotechnology for Commercial Production of Vaccines and Biopharmaceuticals;2023

2. Predicting Protein–Ligand Docking Structure with Graph Neural Network;Journal of Chemical Information and Modeling;2022-06-14

3. Comparable efficacy and safety between LY2963016 insulin glargine and insulin glargine (Lantus®) in Chinese patients with type 1 diabetes: A phase III , randomized, controlled trial;Diabetes, Obesity and Metabolism;2021-07-08

4. Biologics vs. small molecules: Drug costs and patient access;Medicine in Drug Discovery;2021-03